These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Inhibition of liver lysosomal acid phospholipase A1 by blood serum proteins. Löffler BM; Bohn E; Kunze H Biochem Int; 1988 Nov; 17(5):965-71. PubMed ID: 3254168 [TBL] [Abstract][Full Text] [Related]
23. [The enzymatic system of phospholipid deacylation-reacylation in rat liver lysosomal membranes]. Batikian TB; Karagezian KG; Tadevosian IuV Biokhimiia; 1990 Sep; 55(9):1700-6. PubMed ID: 2078642 [TBL] [Abstract][Full Text] [Related]
24. [The effect of single and repeated administration of chloroquine on the activity of lysosomal proteinases in rat liver cells]. Korolenko TA; Rukavishnikova EV; Pupyshev AB Vopr Med Khim; 1990; 36(6):20-3. PubMed ID: 2075715 [TBL] [Abstract][Full Text] [Related]
25. Investigating the role of endogenous opioid system in chloroquine-induced phospholipidosis in rat liver by morphological, biochemical and molecular modelling studies. Malek MR; Ahmadian S; Dehpour AR; Ebrahim-Habibi A; Shafizadeh M; Kashani-Amin E Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1575-1583. PubMed ID: 32367550 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of lysosomal phospholipase A and phospholipase C by chloroquine and 4,4'-bis(diethylaminoethoxy) alpha, beta-diethyldiphenylethane. Matsuzawa Y; Hostetler KY J Biol Chem; 1980 Jun; 255(11):5190-4. PubMed ID: 6246100 [No Abstract] [Full Text] [Related]
27. Inhibition of purified lysosomal phospholipase A1 by beta-adrenoceptor blockers. Pappu AS; Yazaki PJ; Hostetler KY Biochem Pharmacol; 1985 Feb; 34(4):521-4. PubMed ID: 2857566 [TBL] [Abstract][Full Text] [Related]
28. Effects of the serine protease inhibitors FOY and FOY 305 on phospholipase A1 (EC 3.1.1.32) activity in rat - liver lysosomes. Kunze H; Bohn E Pharmacol Res Commun; 1983 May; 15(5):451-9. PubMed ID: 6412250 [TBL] [Abstract][Full Text] [Related]
29. Effects of chloroquine and 4,4'-bis(diethylaminoethoxy)alpha, beta-diethyldiphenylethane on the incorporation of [3H]glycerol into the phospholipids of rat liver lysosomes and other subcellular fractions, in vivo. Matsuzawa Y; Hostetler KY Biochim Biophys Acta; 1980 Dec; 620(3):592-602. PubMed ID: 6263327 [No Abstract] [Full Text] [Related]
30. Studies on the occurrence and properties of lysosomal phospholipases A1 and A2 and the degradation of phosphatidic acid in rat liver lysosomes. Stoffel W; Trabert U Hoppe Seylers Z Physiol Chem; 1969 Jul; 350(7):836-44. PubMed ID: 4308852 [No Abstract] [Full Text] [Related]
31. Degradation of bis(monoacylglycero)phosphate by an acid phosphodiesterase in rat liver lysosomes. Matsuzawa Y; Hostetler KY J Biol Chem; 1979 Jul; 254(13):5997-6001. PubMed ID: 36389 [TBL] [Abstract][Full Text] [Related]
32. Studies on the liberation of fatty acids from 2-lysophosphatidylcholine by a liver lysosomal enzyme activity from chloroquine-treated rats. Pakalapati G; Debuch H Hoppe Seylers Z Physiol Chem; 1982 Jun; 363(6):573-80. PubMed ID: 7106704 [TBL] [Abstract][Full Text] [Related]
33. Modulation of the in vitro activity of lysosomal phospholipase A1 by membrane lipids. Piret J; Schanck A; Delfosse S; Van Bambeke F; Kishore BK; Tulkens PM; Mingeot-Leclercq MP Chem Phys Lipids; 2005 Jan; 133(1):1-15. PubMed ID: 15589222 [TBL] [Abstract][Full Text] [Related]
34. Effects of chloroquine on lysosomes and endocytosis by liver cells in vivo. Korolenko TA; Rukavishnikova EV; Safina AF; Mynkina GI; Vereshchagin EI Acta Biol Hung; 1991; 42(1-3):301-9. PubMed ID: 1844318 [TBL] [Abstract][Full Text] [Related]
35. Purification of lysosomal phospholipase A and demonstration of proteins that inhibit phospholipase A in a lysosomal fraction from rat kidney cortex. Hostetler KY; Gardner MF; Giordano JR Biochemistry; 1986 Oct; 25(21):6456-61. PubMed ID: 3790533 [TBL] [Abstract][Full Text] [Related]
37. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids. Kishore BK; Lambricht P; Laurent G; Maldague P; Wagner R; Tulkens PM J Pharmacol Exp Ther; 1990 Nov; 255(2):875-85. PubMed ID: 1700819 [TBL] [Abstract][Full Text] [Related]
38. Amphiphilic cationic drugs and phospholipids influence the activities of beta-galactosidase and beta-glucosidase from liver lysosomal fraction of untreated rats. Harder A; Dodt G; Debuch H Biol Chem Hoppe Seyler; 1985 Feb; 366(2):189-93. PubMed ID: 2985099 [TBL] [Abstract][Full Text] [Related]
39. Pentamidine accumulates in rat liver lysosomes and inhibits phospholipid degradation. Glaumann H; Bronner U; Ericsson O; Gustafsson LL; Rombo L Pharmacol Toxicol; 1994 Jan; 74(1):17-22. PubMed ID: 8159632 [TBL] [Abstract][Full Text] [Related]
40. The role of the intralysosomal pH in the control of autophagic proteolytic flux in rat hepatocytes. Luiken JJ; Aerts JM; Meijer AJ Eur J Biochem; 1996 Feb; 235(3):564-73. PubMed ID: 8654402 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]